Bessemer Group Portfolio holdings
AUM
$61.6B
1-Year Return
25.88%
This Quarter Return
+13.01%
1 Year Return
+25.88%
3 Year Return
+112.29%
5 Year Return
+188.53%
10 Year Return
+439.25%
AUM
$51.3B
AUM Growth
+$5.78B
(+13%)
Cap. Flow
+$460M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
2,345
New
152
Increased
681
Reduced
743
Closed
194
Top Buys
| 1 |
Broadcom
AVGO
|
+$271M |
| 2 |
Gartner
IT
|
+$270M |
| 3 |
AutoZone
AZO
|
+$144M |
| 4 |
Honeywell
HON
|
+$136M |
| 5 |
Qualcomm
QCOM
|
+$135M |
Top Sells
| 1 |
Amphenol
APH
|
+$213M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$191M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$169M |
| 4 |
Synopsys
SNPS
|
+$158M |
| 5 |
PepsiCo
PEP
|
+$158M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 12.68% |
| 3 | Healthcare | 11.05% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
AngloGold Ashanti
AU
$31.3B
| $8.06M | 0.02% |
431,032
-47,113
| -10% | -$881K |
|
327
Gilead Sciences
GILD
$144B
| $7.93M | 0.02% |
97,859
+5,992
| +7% | +$486K |
|
328
Tesla
TSLA
$1.12T
| $7.6M | 0.01% |
30,587
-1,543
| -5% | -$383K |
|
329
Stevanato
STVN
$7.25B
| $7.56M | 0.01% |
276,895
+52,901
| +24% | +$1.44M |
|
330
PNC Financial Services
PNC
$78.9B
| $7.52M | 0.01% |
48,533
-876
| -2% | -$136K |
|
331
MKS Inc. Common Stock
MKSI
$7.27B
| $7.5M | 0.01% |
72,909
+15,847
| +28% | +$1.63M |
|
332
AMN Healthcare
AMN
$798M
| $7.3M | 0.01% |
97,482
+29,267
| +43% | +$2.19M |
|
333
AstraZeneca
AZN
$252B
| $7.29M | 0.01% |
108,234
+820
| +0.8% | +$55.2K |
|
334
Guidewire Software
GWRE
$21.6B
| $7.24M | 0.01% |
66,429
+60,863
| +1,093% | +$6.64M |
|
335
RTX Corp
RTX
$203B
| $7.15M | 0.01% |
85,018
+51,715
| +155% | +$4.35M |
|
336
Salesforce
CRM
$240B
| $7.08M | 0.01% |
26,911
-855
| -3% | -$225K |
|
337
Bristol-Myers Squibb
BMY
$96.1B
| $7.02M | 0.01% |
136,780
+42,674
| +45% | +$2.19M |
|
338
Tango Therapeutics
TNGX
$759M
| $7.01M | 0.01% |
708,384
| – | – |
|
339
Revolution Medicines
RVMD
$7.65B
| $6.98M | 0.01% |
243,442
| – | – |
|
340
Kanzhun
BZ
$11.1B
| $6.89M | 0.01% |
414,677
-65,168
| -14% | -$1.08M |
|
341
Texas Roadhouse
TXRH
$11.2B
| $6.83M | 0.01% |
55,892
+55,854
| +146,984% | +$6.83M |
|
342
Cigna
CI
$80.6B
| $6.82M | 0.01% |
22,789
-687
| -3% | -$206K |
|
343
Becton Dickinson
BDX
$54.6B
| $6.8M | 0.01% |
27,869
+10,161
| +57% | +$2.48M |
|
344
DuPont de Nemours
DD
$32.1B
| $6.55M | 0.01% |
85,121
+11,071
| +15% | +$852K |
|
345
BlackLine
BL
$3.38B
| $6.49M | 0.01% |
103,915
+101,551
| +4,296% | +$6.34M |
|
346
TFI International
TFII
$7.68B
| $6.48M | 0.01% |
47,473
| – | – |
|
347
Relay Therapeutics
RLAY
$702M
| $6.44M | 0.01% |
584,463
| – | – |
|
348
SPDR Gold Trust
GLD
$115B
| $6.41M | 0.01% |
33,546
-795
| -2% | -$152K |
|
349
Vertex
VERX
$3.95B
| $6.21M | 0.01% |
+230,403
| New | +$6.21M |
|
350
Pegasystems
PEGA
$9.75B
| $6.03M | 0.01% |
246,640
| – | – |
|